financetom
Business
financetom
/
Business
/
Albemarle CEO says 'math doesn't work' for US lithium refinery project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Albemarle CEO says 'math doesn't work' for US lithium refinery project
May 25, 2025 11:50 PM

(Reuters) -Albemarle's stalled plans to build the largest U.S. lithium refinery remain on hold due to the ongoing global glut of the battery metal that has dragged down market prices, the company's CEO told Reuters on Thursday.

That market malaise leaves the U.S. without a major site to process lithium - the cornerstone metal of the energy transition - and essentially dampens efforts by U.S. President Donald Trump and other Washington officials to bolster the country's minerals supply chain and curb its reliance on China.

The U.S. refines only small amounts of the ultralight metal and has only one lithium mine, in Nevada, controlled by Albemarle. Last year, the company paused plans to build a $1.3 billion processing plant in South Carolina due in part to overproduction from Chinese rivals.

While lithium prices can vary by region and type, an index of prices tracked by Benchmark Mineral Intelligence has dropped by 74% in the past two years.

"We've been wanting to build this Western supply chain. The economics just aren't there to build that plant out in South Carolina," Albemarle CEO Kent Masters told Reuters. "The math doesn't work today."

The company, which posted better-than-expected quarterly results on Wednesday, has a lithium price at which it would resume the project's development, but Masters declined to name it.

"We don't have the confidence to say where (the lithium price) is or where it's going, which is why we've kind of gone to the strategy we have of making sure that we can compete at the bottom of the cycle," said Masters.

Western minerals supply chains may need some kind of government support in order to develop projects and offset global competition, he added.

"I don't think private companies are going to be able to do it on their own," Masters said.

M&A

While Rio Tinto and other rivals have been buying lithium assets during the downturn, Masters said that Albemarle has yet to find an interesting target.

"We don't have that war chest to go out and look at M&A activity the way we might have if prices were at a different level," he said. "If we saw some super quality resources we could go after, that might be a little different."

In Chile, Albemarle is "pretty focused" on its work in the Salar de Atacama and while it considered bidding to access other salars, the company "didn't find them interesting," Masters said.

Albemarle also is investing in direct lithium extraction projects in Chile and the United States, but Masters declined to say when either might progress.

Amid the market turmoil, Albemarle held auctions for the battery metal as part of a bid to generate higher returns. Those auctions were paused while the company prepared for its quarterly earnings and may soon resume, Masters said.

"We kind of like the idea of understanding pricing better and getting more transparency in the market," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OGE Energy's Q2 Earnings, Operating Revenue Rise; 2024 Consolidated EPS Outlook Reaffirmed
OGE Energy's Q2 Earnings, Operating Revenue Rise; 2024 Consolidated EPS Outlook Reaffirmed
Aug 7, 2024
07:59 AM EDT, 08/07/2024 (MT Newswires) -- OGE Energy ( OGE ) reported Q2 earnings Wednesday of $0.51 per share, up from $0.44 a year earlier. Analysts polled by Capital IQ expected $0.46. Operating revenue for the quarter ended June 30 was $662.6 million, up from $605 million a year earlier. Analysts' estimate wasn't available for comparison. The company said...
Intra-Cellular Therapies Q2 Net Loss Narrows, Revenue Rises
Intra-Cellular Therapies Q2 Net Loss Narrows, Revenue Rises
Aug 7, 2024
08:00 AM EDT, 08/07/2024 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) reported a Q2 net loss Wednesday of $0.16 per diluted share, narrowing from a loss of $0.45 a year earlier. Analysts polled by Capital IQ expected a loss of $0.21. Total revenue for the quarter ended June 30 was $161.4 million, compared with $110.8 million a year earlier....
Emerson's quarterly earnings rise on measurement instruments demand
Emerson's quarterly earnings rise on measurement instruments demand
Aug 7, 2024
(Reuters) - Emerson Electric ( EMR ) reported higher third-quarter earnings on Wednesday, aided by demand for its unit which makes valves, regulators and actuators. Emerson's measurement and analytical devices have continued to benefit from manufacturers and end customers across the chemical, oil and gas industries. The company however has pivoted its focus on automation products and services, encouraged by...
Brazilian Inter&Co's second-quarter profit jumps as user base grows
Brazilian Inter&Co's second-quarter profit jumps as user base grows
Aug 7, 2024
Aug 7 (Reuters) - Brazilian digital bank Inter&Co reported on Wednesday that its net income in the second quarter more than tripled, helped by a larger customer base and larger return on equity. Inter&Co's profit rose to 223 million reais ($39.42 million) in the quarter, compared with 64 million reais in the same period last year. The firm's return on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved